498
Participants
Start Date
November 19, 2020
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Radiopaque Etonogestrel (ENG) Implant
68 mg subdermal implant
Icahn School of Medicine at Mount Sinai (Site 0155), New York
Columbia Univ. Medical Center (Site 0118), New York
Montefiore Medical Center (Site 0103), The Bronx
University of Pittsburgh - Magee Womens Hospital (Site 0100), Pittsburgh
OB/GYN Associates of Erie (Site 0183), Erie
Johns Hopkins Bayview Medical Center (Site 0225), Baltimore
Tidewater Clinical Research Inc (Site 0162), Norfolk
Eastern Virginia Medical School (Site 0146), Norfolk
Carolina Women's Research and Wellness Center (Site 0154), Durham
Eastern Carolina Women's Center (Site 0159), New Bern
Palmetto Clinical Research (Site 0133), Summerville
Mount Vernon Clinical Research (Site 0111), Sandy Springs
University Of Florida (Site 0144), Jacksonville
Emerald Coast Obstetrics and Gynecology (Site 0203), Panama City
Lenus Research & Medical Group Llc (Site 0102), Sweetwater
Comprehensive Clinical Trials LLC (Site 0101), West Palm Beach
Alabama Clinical Therapeutics (Site 0222), Birmingham
University of Tennessee Medical Center Knoxville (Site 0218), Knoxville
Metro Jackson OBGYN/SKYCRNG (Site 0233), Jackson
The Ohio State University (Site 0176), Columbus
Velocity Clinical Research, Cincinnati (Site 0230), Cincinnati
HWC Women's Research Center (Site 0199), Englewood
Indiana University (Site 0220), Indianapolis
Michigan Medicine (Site 0108), Ann Arbor
Saginaw Valley Medical Research Group, LLC (Site 0198), Saginaw
Planned Parenthood of North Central States (PPNCS) (Site 0113), Minneapolis
Planned Parenthood of Illinois (PPIL) (Site 0200), Chicago
Planned Parenthood of the Saint Louis Region & Southwest Missouri (Site 0158), St Louis
Washington University (Site 0129), St Louis
Cypress Medical Research Center (Site 0226), Wichita
Southern Clinical Research Associates (Site 0219), Metairie
Signature Gyn Services (Site 0201), Fort Worth
Planned Parenthood of the Gulf Coast (Site 0106), Houston
University of Texas Health Science Center (Site 0178), Houston
Advances in Health, Inc. (Site 0209), Pearland
Centex Studies, Inc. (Site 0171), Houston
Gadolin Research (Site 0232), Beaumont
Tekton Research - Floyd Curl Drive (Site 0228), San Antonio
Planned Parenthood of the Rocky Mountains (Site 0196), Denver
Physicians' Research Options, LLC (Site 0166), Lakewood
Comprehensive Womens Health Center (Site 0194), Denver
Rosemark (Site 0177), Idaho Falls
Physicians' Research Options, LLC (Site 0204), Pleasant Grove
JBR Clinical Research (Site 0174), Salt Lake City
Desert Star Family Planning (Site 0193), Phoenix
Precision Trials (Site 0187), Phoenix
Visions Clinical Research Tucson (Site 0134), Tucson
Albuquerque Clinical Trials (Site 0210), Albuquerque
Bosque Women's Care (Site 0211), Albuquerque
Office of Edmond Pack, MD (Site 0168), Las Vegas
Essential Access Health (Site 0163), Los Angeles
Matrix Clinical Research Inc (Site 0105), Los Angeles
University of California Los Angeles (Site 0119), Los Angeles
Stanford University (Site 0112), Stanford
University of California, Davis (Site 0124), Sacramento
Oregon Health Sciences University Hospital (Site 0128), Portland
Seattle Women's: Health, Research, Gynecology (Site 0149), Seattle
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky (Site 0110), Seattle
Multicare Health System Institute for Research and Innovation (Site 0188), Cheney
North Spokane Women's Clinic (Site 0137), Spokane
McFarland Clinic, PC (Site 0217), Ames
Boston University Medical Center (Site 0167), Boston
Planned Parenthood League of Massachusetts (Site 0135), Boston
Capital Health OB/GYN- Lawrenceville (Site 0190), Lawrenceville
Advance Medical Concept PSC (Site 0313), Cidra
Clinical Research Puerto Rico Inc (Site 0302), San Juan
FDI Clinical Research (Site 0305), San Juan
Organon and Co
INDUSTRY